AppBlogHilfeonvista bank
Werbung ausblenden
Aktie • Biotechnologie

CYMABAY THERAPEUTICS

WKN
A116DD
Ticker
CBAY
• C0I
ISIN
US23257D1037
Marktkapitalisierung
–
Dividendenrendite
–
KGV
–
Gewinn pro Aktie
–
Vola 30 Tage
67,38 %
theScreener Rating
–

Unternehmens­daten

Stammdaten zu CYMABAY THERAPEUTICS

WKN
A116DD
ISIN
US23257D1037
Home-Symbol
CBAY
Symbol
C0I
Branche
Biotechnologie
Sektor
Chemie / Pharma / Gesundheit
Unternehmen
Land

Marktdaten

Marktkapitalisierung
–
Anzahl Aktien
–
Streubesitz
–

Mitglieder & Anteilseigner

Anteilseigner

Avoro Capital Advisor LLCBlackRock Fund AdvisorsRA Capital Management LPJanus Henderson Investors US LLCThe Vanguard Group, Inc.T. Rowe Price Associates, Inc. (Investment Management)Perceptive Advisors LLCJennison Associates LLCFranklin Advisers, Inc.Holocene Advisors, LPSSgA Funds Management, Inc.Octagon Capital Advisors LPAdage Capital Management LPPoint72 Asset Management LPGeode Capital Management LLCFidelity Management & Research Co. LLCFred Alger Management LLCCormorant Asset Management LPForesite Capital Management LLCVestal Point Capital LP
  • Avoro Capital Advisor LLC (9,68 %)
  • BlackRock Fund Advisors (7,57 %)
  • RA Capital Management LP (6,05 %)
  • Janus Henderson Investors US LLC (5,28 %)
  • The Vanguard Group, Inc. (5,24 %)
  • T. Rowe Price Associates, Inc. (Investment Management) (3,81 %)
  • Perceptive Advisors LLC (3,51 %)
  • Jennison Associates LLC (3,48 %)
  • Franklin Advisers, Inc. (2,83 %)
  • Holocene Advisors, LP (2,61 %)
  • SSgA Funds Management, Inc. (2,44 %)
  • Octagon Capital Advisors LP (2,33 %)
  • Adage Capital Management LP (2,29 %)
  • Point72 Asset Management LP (2,24 %)
  • Geode Capital Management LLC (2,07 %)
  • Fidelity Management & Research Co. LLC (2,03 %)
  • Fred Alger Management LLC (1,71 %)
  • Cormorant Asset Management LP (1,57 %)
  • Foresite Capital Management LLC (1,56 %)
  • Vestal Point Capital LP (1,42 %)

Kontakt

Werbung ausblenden